大研生醫國際股份有限公司 Approved
最後更新時間 2025/05/16 , 03:07 AM
最後更新時間 2025/05/16 , 03:07 AM
負責人
Zhang,Jia-Ming
統一編號
50784323
成立日期
2018/06/20
資本額
NT$1,000,000,000
實收資本額
NT$600,024,170
股票代號
7780
電話
02-23650103
地址
12F, No. 37, Sec. 3, Roosevelt Rd., Da’an Dist., Taipei City, 106, Taiwan
網站
董監事
姓名 職稱 持有股份 代表法人
Zhang,Jia-Ming Chairman 97.50% SUNFUN INFO CO., LTD.
Zhang,Li Director 97.50% SUNFUN INFO CO., LTD.
Lin,Dong-Qing Director 97.50% SUNFUN INFO CO., LTD.
Shu,Yu-Fan Director 97.50% SUNFUN INFO CO., LTD.
Wu,Xin-Fang Director 0.00%
Xie,Jun-Hong Director 0.00%
Lin,Guan-Yu Independent Director 0.00%
Chen,Yan-Ting Independent Director 0.00%
Lin,Qi-Hong Independent Director 0.00%
營業項目
  • Wholesale of Other Food(454999)
  • Retail Sale of Other Food, Beverages and Tobacco in Specialized Stores(472999)
  • 公司歷程
  • Change Capital to 1,000,000,000
    2024/05/29
  • Change Person in Charge to Zhang,Jia-Ming
    2024/03/12
  • Change Capital to 300,000,000
    2020/10/07
  • Change Capital to 100,000,000
    2018/12/06
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 334,774 1,362,387 1,190,415
    Operating cost 111,753 506,170 376,658
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 223,021 856,217 813,757
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 223,021 856,217 813,757
    Operating expenses 186,236 707,302 609,608
    Other gain (loss), net - - -
    Operating profit (loss) 36,785 148,915 204,149
    Non-operating income and expenses 94,468 -9,314 -8,800
    Net profit (loss) before tax 131,253 139,601 195,349
    Income tax expense (benefits) 26,251 33,022 34,995
    Net profit (loss) of ongoing business for the current period 105,002 106,579 160,354
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 105,002 106,579 160,354
    Other comprehensive profit (loss), net 4,435 -859 -
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 109,437 105,720 160,354
    Net profit (loss) attributable to owners of parent company 105,002 106,579 -
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company 109,437 105,720 -
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 1 2 10
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities 52,340 51,751 -
    Net cash inflows (outflows) from investing activities -3,901 84,092 -
    Net cash inflow (outflow) from financing activities -841 717,675 -
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 4,435 -859 -
    Increase (decrease) in cash and cash equivalents in the current period 52,033 852,659 -
    Beginning balance of cash and cash equivalents 1,139,724 287,065 -
    Ending balance of cash and cash equivalents 1,191,757 1,139,724 -
    項目 2025 2024 2023
    Current asset 1,640,982 1,511,468 729,454
    Non-current asset 23,152 26,333 12,438
    Total asset 1,664,134 1,537,801 741,892
    Current liability 445,960 230,366 445,010
    Non-current liability 757 446 49,560
    Total liability 446,717 230,812 494,570
    share capital 600,024 600,024 155,400
    Equity - secruity token - - -
    capital reserve 474,060 624,060 -
    retained earning 139,757 83,764 91,922
    Other equity 3,576 -859 -
    Treasury stock - - -
    Total equity attributable to owners of parent company 1,217,417 1,306,989 -
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 1,217,417 1,306,989 247,322
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 20 21 15
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    存款不足之退票事宜
    時間 金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 大研バイオメディカル
  • 好攝護
  • 倍力他命BELINAMIN
  • 好記易
  • SesaVita
  • 攝護易
  • NightGABA
  • 糖必穩
  • GC 設計字
  • 糖易定
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Trademark opposition
    2021
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。